Comparison of Pharmacokinetics, Safety, and Immunogenicity of Process-Changed?? CMAB007 and Xolair in a Randomized, Double-blind, Parallel Controlled, Single-dose Study in Healthy Chinese Male Subjects

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: be16ec20a3031734c958d4e73f4b35ebd1fe3699
First added on: Apr 24, 2026